Login

Research: It's All About Patients - Dr. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Research: It's All About Patients

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Mission is to partner with entrepreneurs solving big problems|Ray Lane,Managing Partner,GreatPoint Ventures
00:00:00
Interested in the development and characterization of animal models of human neurodegenerative diseases / Matthew Frosch, M.D., Ph.D.
00:10:00
Guiding Investment Strategies Amid Market Volatility: Penny Pennington's Perspective | Penny Pennington, Managing Partner , Edward Jones Investments LLC.
00:10:00
Williams Financial Group advocates for retirement protection, partnering with Protecting Your Retirement, LLC, in financial services.
00:10:00
Tembo Gold's Tanzania Project and Future Plans with Barrick
00:10:00
Economist David Gladstone Forecasts Prolonged Elevated Produce Prices Pending Further Economic Opening|David J. Gladstone, Chairman & CEO,Gladstone Commercial Corporation
00:10:00
Christoph Vilanek is the CEO of Freenet.
00:10:00
Ruffer LLP: An Unconstrained Investment Strategy
00:10:00
HSBC's Strategic Acquisition of SVB UK and Global Expansion Plans | Noel Quinn, CEO ,  HSBC.
00:10:00
Resolute Mining's Automation Journey at Syama Gold Mine: Enhancing Safety and Efficiency in Mali
00:10:00
Future Growth in Luxury, Lifestyle, and Sustainability: Accor CEO Sébastien Bazin at Skift Global Forum | Sébastien Bazin, CEO , Accor SA.
00:00:00
Jonathan N. Johnson, M.D. Pediatric Cardiologist, Mayo Clinic / Mayo Clinic Explains Congenital Heart Defects

© 2017 - Neuhu+